CANADIAN DRUG RE IMPORTATION

TSCL & Drug Reimportation
The implementation of the Medicare Part D prescription drug benefit led some in Congress to believe that the prescription drug situation was solved for most seniors. So, it became more difficult to garner support in Congress for reimportation bills at the end of the 109th session. However, the overall results of the Medicare Part D drug benefit have not yet been fully determined.
Simply put, pharmaceutical companies have been over-charging the American consumer for prescription drugs compared with costs for the same drugs in Canada and Europe. Pharmaceutical companies have made bulk deals with governments (such as Canada) where they still make substantial profits while charging much less for prescriptions.
TSCL believes that this is not a safety issue. Rather, it's an issue of pharmaceutical companies charging excessive prices in part due to their extraordinary clout and influence in the political process. TSCL supported bills in the House (H.R. 328) and Senate (S.334 and S.109) that would - in our view - make safe and secure prescription drug reimportation a reality.